Global Pneumococcal Polysaccharide Vaccine Market Intelligence Report for Comprehensive Information 2017-2025

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Aug-2018   |    Format :PDF   |    Number of Pages : 93
This report studies the global market size of Pneumococcal Polysaccharide Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pneumococcal Polysaccharide Vaccine in these regions.
This research report categorizes the global Pneumococcal Polysaccharide Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age.
The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23. 
In 2017, the global Pneumococcal Polysaccharide Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Pneumococcal Polysaccharide Vaccine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Pneumococcal Polysaccharide Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Pneumococcal Polysaccharide Vaccine include
    Merck & Co., Inc.
    Pfizer Inc.
    Glaxosmithkline Plc.
    Sanofi Pasteur
    China National Biotec Group
    Astellas Pharma Inc
    Serum Institute of India Pvt. Ltd

Market Size Split by Type
    Single Dose Vial
    Pre-Filled Syringe
Market Size Split by Application
    Children (2-10 Age)
    Adult (10-64 Age)
    Geriatric (More Than 65 Age)

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Pneumococcal Polysaccharide Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Pneumococcal Polysaccharide Vaccine market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Pneumococcal Polysaccharide Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Pneumococcal Polysaccharide Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Pneumococcal Polysaccharide Vaccine submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pneumococcal Polysaccharide Vaccine are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pneumococcal Polysaccharide Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Pneumococcal Polysaccharide Vaccine Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type
        1.4.2 Single Dose Vial
        1.4.3 Pre-Filled Syringe
    1.5 Market by Application
        1.5.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application
        1.5.2 Children (2-10 Age)
        1.5.3 Adult (10-64 Age)
        1.5.4 Geriatric (More Than 65 Age)
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Pneumococcal Polysaccharide Vaccine Market Size
        2.1.1 Global Pneumococcal Polysaccharide Vaccine Revenue 2016-2025
        2.1.2 Global Pneumococcal Polysaccharide Vaccine Sales 2016-2025
    2.2 Pneumococcal Polysaccharide Vaccine Growth Rate by Regions
        2.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Regions
        2.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
        3.1.1 Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
        3.1.2 Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers
        3.1.3 Global Pneumococcal Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI)
    3.2 Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers
        3.2.1 Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2016-2018)
        3.2.2 Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2016-2018)
    3.3 Pneumococcal Polysaccharide Vaccine Price by Manufacturers
    3.4 Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Product Types
        3.4.1 Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Pneumococcal Polysaccharide Vaccine Product Category
        3.4.3 Date of International Manufacturers Enter into Pneumococcal Polysaccharide Vaccine  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type
    4.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type
    4.3 Pneumococcal Polysaccharide Vaccine Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Pneumococcal Polysaccharide Vaccine Breakdown Data by Application

6 North America
    6.1 North America Pneumococcal Polysaccharide Vaccine by Countries
        6.1.1 North America Pneumococcal Polysaccharide Vaccine Sales by Countries
        6.1.2 North America Pneumococcal Polysaccharide Vaccine Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Pneumococcal Polysaccharide Vaccine by Type
    6.3 North America Pneumococcal Polysaccharide Vaccine by Application
    6.4 North America Pneumococcal Polysaccharide Vaccine by Company

7 Europe
    7.1 Europe Pneumococcal Polysaccharide Vaccine by Countries
        7.1.1 Europe Pneumococcal Polysaccharide Vaccine Sales by Countries
        7.1.2 Europe Pneumococcal Polysaccharide Vaccine Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Pneumococcal Polysaccharide Vaccine by Type
    7.3 Europe Pneumococcal Polysaccharide Vaccine by Application
    7.4 Europe Pneumococcal Polysaccharide Vaccine by Company

8 Asia Pacific
    8.1 Asia Pacific Pneumococcal Polysaccharide Vaccine by Countries
        8.1.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Countries
        8.1.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Pneumococcal Polysaccharide Vaccine by Type
    8.3 Asia Pacific Pneumococcal Polysaccharide Vaccine by Application
    8.4 Asia Pacific Pneumococcal Polysaccharide Vaccine by Company

9 Central & South America
    9.1 Central & South America Pneumococcal Polysaccharide Vaccine by Countries
        9.1.1 Central & South America Pneumococcal Polysaccharide Vaccine Sales by Countries
        9.1.2 Central & South America Pneumococcal Polysaccharide Vaccine Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Pneumococcal Polysaccharide Vaccine by Type
    9.3 Central & South America Pneumococcal Polysaccharide Vaccine by Application
    9.4 Central & South America Pneumococcal Polysaccharide Vaccine by Company

10 Middle East and Africa
    10.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine by Countries
        10.1.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Countries
        10.1.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine by Type
    10.3 Middle East and Africa Pneumococcal Polysaccharide Vaccine by Application
    10.4 Middle East and Africa Pneumococcal Polysaccharide Vaccine by Company

11 Company Profiles
    11.1 Merck & Co., Inc.
        11.1.1 Merck & Co., Inc. Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Pneumococcal Polysaccharide Vaccine
        11.1.4 Pneumococcal Polysaccharide Vaccine Product Description
        11.1.5 Recent Development
    11.2 Pfizer Inc.
        11.2.1 Pfizer Inc. Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Pneumococcal Polysaccharide Vaccine
        11.2.4 Pneumococcal Polysaccharide Vaccine Product Description
        11.2.5 Recent Development
    11.3 Glaxosmithkline Plc.
        11.3.1 Glaxosmithkline Plc. Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Pneumococcal Polysaccharide Vaccine
        11.3.4 Pneumococcal Polysaccharide Vaccine Product Description
        11.3.5 Recent Development
    11.4 Sanofi Pasteur
        11.4.1 Sanofi Pasteur Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Pneumococcal Polysaccharide Vaccine
        11.4.4 Pneumococcal Polysaccharide Vaccine Product Description
        11.4.5 Recent Development
    11.5 China National Biotec Group
        11.5.1 China National Biotec Group Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Pneumococcal Polysaccharide Vaccine
        11.5.4 Pneumococcal Polysaccharide Vaccine Product Description
        11.5.5 Recent Development
    11.6 Astellas Pharma Inc
        11.6.1 Astellas Pharma Inc Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Pneumococcal Polysaccharide Vaccine
        11.6.4 Pneumococcal Polysaccharide Vaccine Product Description
        11.6.5 Recent Development
    11.7 Serum Institute of India Pvt. Ltd
        11.7.1 Serum Institute of India Pvt. Ltd Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Pneumococcal Polysaccharide Vaccine
        11.7.4 Pneumococcal Polysaccharide Vaccine Product Description
        11.7.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Pneumococcal Polysaccharide Vaccine Raw Material
        13.1.2 Pneumococcal Polysaccharide Vaccine Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Pneumococcal Polysaccharide Vaccine
    Figure Global Pneumococcal Polysaccharide Vaccine Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Pneumococcal Polysaccharide Vaccine Production Market Share by Types (Product Category) in 2017
    Figure Single Dose Vial Product Picture
    Table Major Manufacturers of Single Dose Vial
    Figure Pre-Filled Syringe Product Picture
    Table Major Manufacturers of Pre-Filled Syringe
    Table Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Children (2-10 Age)
    Figure Adult (10-64 Age)
    Figure Geriatric (More Than 65 Age)
    Figure Pneumococcal Polysaccharide Vaccine Report Years Considered
    Figure Global Pneumococcal Polysaccharide Vaccine Market Size 2016-2025 (Million US$)
    Figure Global Pneumococcal Polysaccharide Vaccine Sales 2016-2025 (K Units)
    Table Global Pneumococcal Polysaccharide Vaccine Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Pneumococcal Polysaccharide Vaccine Sales by Regions 2016-2025 (K Units)
    Table Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions 2016-2025
    Figure Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions 2016-2025
    Figure 2017 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions
    Table Global Pneumococcal Polysaccharide Vaccine Revenue by Regions 2016-2025 (Million US$)
    Table Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions 2016-2025
    Figure Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions
    Table Global Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2016-2018) (K Units)
    Table Global Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2016-2018)
    Figure Global Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2017
    Table Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
    Table Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2016-2018)
    Figure Pneumococcal Polysaccharide Vaccine Value Share by Manufacturers in 2017
    Table Global Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Pneumococcal Polysaccharide Vaccine Price (2016-2018) (USD/Unit)
    Table Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Pneumococcal Polysaccharide Vaccine Product Category
    Table Date of International Manufacturers Enter into Pneumococcal Polysaccharide Vaccine Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2025) (K Units)
    Table Global Pneumococcal Polysaccharide Vaccine Sales Share by Type (2016-2025)
    Figure Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2025)
    Figure Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2017
    Table Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2025) (Million US$)
    Table Global Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2016-2025)
    Figure Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2025)
    Figure Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type in 2017
    Table Pneumococcal Polysaccharide Vaccine Price by Type 2013-2018 (USD/Unit)
    Table Global Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2025) (K Units)
    Table Global Pneumococcal Polysaccharide Vaccine Sales Share by Application (2016-2025)
    Figure Global Sales Pneumococcal Polysaccharide Vaccine Market Share by Application (2016-2025)
    Figure Global Sales Pneumococcal Polysaccharide Vaccine Market Share by Application (2016-2025)
    Figure North America Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2025 (K Units)
    Figure North America Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Pneumococcal Polysaccharide Vaccine Sales by Countries (2016-2025) (K Units)
    Table North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries
    Table North America Pneumococcal Polysaccharide Vaccine Revenue by Countries (2016-2025) (Million US$)
    Table North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries
    Figure United States Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure United States Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2025) (K Units)
    Table North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2025)
    Figure 2017 North America Pneumococcal Polysaccharide Vaccine Market Share by Type
    Table North America Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2025) (K Units)
    Table North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2025)
    Figure 2017 North America Pneumococcal Polysaccharide Vaccine Market Share by Application
    Table North America Pneumococcal Polysaccharide Vaccine Sales by Company (2016-2018) (K Units)
    Table North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2016-2018)
    Figure North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2017
    Figure Europe Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Pneumococcal Polysaccharide Vaccine Sales by Countries (2016-2025) (K Units)
    Table Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries
    Table Europe Pneumococcal Polysaccharide Vaccine Revenue by Countries (2016-2025) (Million US$)
    Table Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries
    Figure Germany Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (K Units)
    Figure France Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure France Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure UK Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2025) (K Units)
    Table Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Pneumococcal Polysaccharide Vaccine Market Share by Type
    Table Europe Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2025) (K Units)
    Table Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Pneumococcal Polysaccharide Vaccine Market Share by Application
    Table Europe Pneumococcal Polysaccharide Vaccine Sales by Company (2016-2018) (K Units)
    Table Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2016-2018)
    Figure Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2017
    Figure Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries
    Table Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries
    Figure China Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure China Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure India Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Share by Type
    Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Share by Application
    Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2017
    Figure Central & South America Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Pneumococcal Polysaccharide Vaccine Sales by Countries (2016-2025) (K Units)
    Table Central & South America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries
    Table Central & South America Pneumococcal Polysaccharide Vaccine Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries
    Figure Brazil Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2025) (K Units)
    Table Central & South America Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Pneumococcal Polysaccharide Vaccine Market Share by Type
    Table Central & South America Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2025) (K Units)
    Table Central & South America Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Pneumococcal Polysaccharide Vaccine Market Share by Application
    Table Central & South America Pneumococcal Polysaccharide Vaccine Sales by Company (2016-2018) (K Units)
    Table Central & South America Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2016-2018)
    Figure Central & South America Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2017
    Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries
    Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries
    Figure GCC Countries Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Share by Type
    Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Share by Application
    Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2017
    Table Merck & Co., Inc. Company Details
    Table Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Merck & Co., Inc. Recent Development
    Table Pfizer Inc. Company Details
    Table Pfizer Inc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Pfizer Inc. Recent Development
    Table Glaxosmithkline Plc. Company Details
    Table Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Glaxosmithkline Plc. Recent Development
    Table Sanofi Pasteur Company Details
    Table Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Sanofi Pasteur Recent Development
    Table China National Biotec Group Company Details
    Table China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table China National Biotec Group Recent Development
    Table Astellas Pharma Inc Company Details
    Table Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Astellas Pharma Inc Recent Development
    Table Serum Institute of India Pvt. Ltd Company Details
    Table Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Serum Institute of India Pvt. Ltd Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Pneumococcal Polysaccharide Vaccine Value Chain
    Table Typical Suppliers of Key Pneumococcal Polysaccharide Vaccine Raw Material
    Table Pneumococcal Polysaccharide Vaccine Customers List
    Table Pneumococcal Polysaccharide Vaccine Sales Channels
    Table Pneumococcal Polysaccharide Vaccine Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

31-Oct-2018 | Medical Care

Obesity, low BMI linked to increased risk of death, study reveals

The study, published Wednesday in The Lancet Diabetes and Endocrinology and conducted by scientists at London School of Hygiene and Tropical Medicine, revealed that BMI that's either too high o ...

11-Aug-2018 | Electrical & Electronic Device

Samsung leads the pack, Smartphone Market in India Grows 29% In Third Quarter

The shipments of mobile in India are expected to reach the mark of 262 Million units till the fourth quarter arrives. Relying on the numbers, vendors dealing in mobile shipped approximately 80 Mill ...

18-Jul-2018 | Chemicals & Materials

It is Possible!! Can News Reports Be Automated?

Artificial intelligence is currently the hot topic of the town owing to its efficiency and quick work. It is a technology that is currently being used for a number of applications in the various se ...

26-Jun-2018 | Electrical & Electronic Device

Vodafone to Make Stronger Enterprise Portfolio Thus Bolstering Global Telecom Market

Vodafone India is seeking at the broadband segment to fortify its venture portfolio, said the Sunil Sood, the MD and CEO of the telecom company. The carriers had posted 2x development in the enterp ...

17-Apr-2018 | Food Service & Hospitality

Beneficiaries In Puducherry Don’t Use Subsidy To Purchase Food Grain

The Union Food Ministry has received a request from the administration of Puducherry for crediting the subsidy to the beneficiaries’ bank accounts rather than the system distributing subsidiz ...